The Shareholder Revolt at Kestrel Analytics
Kestrel Analytics Ltd is a private company with 1,000,000 shares. Founders hold 450,000; an institutional investor, Northgate, holds 300,000; employees hold 150,000; and a small group of angel investors hold 100,000. The articles contain a pre-emption clause on new share issues and a provision that any issue of shares to a person who is not an existing shareholder requires approval by 75% of the votes cast. Kestrel needs £3,000,000 to avoid insolvency. The board proposes issuing 500,000 new shares to a strategic investor, Vantage, at £6 per share. That price is below the last funding round's £9 per share. Northgate opposes the issue because it will dilute its stake from 30% to 20%. The board argues urgency: the company has six weeks of cash left. The founders support the issue. Employee shareholders are split.
1. Can the board lawfully issue the shares to Vantage without shareholder approval? Analyse the pre-emption clause, the 75% approval provision, and the directors' duties.
Read the worked answer
Pre-emption clause. The clause gives existing shareholders a right of first refusal on new issues. The board must offer the shares to existing shareholders in proportion to their holdings before issuing to Vantage. If the board skips this step, the issue is invalid or at least challengeable. The board could seek a waiver of pre-emption, but a waiver normally requires shareholder approval, often by special resolution.
75% approval provision. An issue to a non-shareholder requires 75% of votes cast. The founders hold 45%, Northgate 30%, employees 15%, angels 10%. If all vote, the founders plus angels reach 55%, short of 75%. Northgate's opposition makes 75% unlikely unless enough employees vote in favour. On these numbers, the board cannot assume approval.
Directors' duties. The board must act in good faith to promote the company's success. Facing insolvency, raising capital is a legitimate purpose. But the board must also consider the interests of creditors as insolvency approaches, and must not issue shares for an improper purpose such as entrenching control. The discounted £6 price is a concern: it may be justifiable as a distress price, but the board must document why £6 is the best available and whether a rights issue at a higher price was explored.
Conclusion. The board cannot lawfully issue to Vantage without either (a) complying with pre-emption or obtaining a waiver, and (b) obtaining 75% approval. It should negotiate with Northgate, consider a rights issue open to all shareholders, and document the urgency and the price rationale.
2. Northgate offers to invest £3,000,000 itself at £9 per share but demands two board seats and a veto over future share issues. How should the board respond?
Read the worked answer
Evaluate Northgate's offer on its merits.
- Price: £9 per share is 50% higher than Vantage's £6, so it is better for existing shareholders and reduces dilution per pound raised.
- Terms: two board seats and a veto over future issues are governance concessions. A veto could paralyse future fundraising and may deter other investors. It may also amount to a class right requiring amendment of the articles.
Legal issues.
- Board seats: the articles may allow the board to appoint directors, or shareholder approval may be needed. Check the appointment provisions.
- Veto: a veto over share issues may conflict with the board's power to manage the company. It should be drafted narrowly, for example a consent right limited to issues below a stated price or above a stated size.
- Equal treatment: other shareholders may object to preferential terms. The board must consider whether the terms are fair and whether a rights issue would be more equitable.
Practical response. The board should not reject the offer outright. It should:
- Ask Northgate to reduce the veto to a narrow consent right and to accept one board seat plus an observer.
- Confirm the £3m is sufficient and available within the six-week window.
- Compare total cost: Vantage at £6 raises £3m for 500,000 shares; Northgate at £9 raises £3m for about 333,333 shares. Northgate is clearly better on dilution.
- Seek a short extension from creditors while negotiating.
- Document the comparison to show the board acted in the company's interest.
Recommendation. Pursue Northgate, subject to narrowing the veto. If Northgate insists on a broad veto, the board should seek shareholder approval and explain the trade-off. The board should not prefer Vantage merely because it preserves founders' control.